Arthralgia, Breast Cancer
Conditions
Brief summary
This is a pilot study of a specifically designed exercise intervention developed for breast cancer patients with aromatase-inhibitor related joint pain.
Interventions
Exercising for 8 weeks using an elastic band
Sponsors
Study design
Eligibility
Inclusion criteria
* Post menopausal women with a history of estrogen positive breast cancer who are receiving aromatase inhibitors for at least one month. * Patients must complain of mild to moderate arthralgia. * Ability to understand and sign informed consent. * Patients meet criteria for low to moderate risk for moderate exercise based oon the ACSM guidelines.
Exclusion criteria
* Inability to comply with study requirements. * Metastatic breast cancer. * Patients with orthopedic or neuromuscular disorders that preclude participation in exercise. * Rheumatoid arthritis. * History of MI, angina or congestive heart failure. * Pregnant or lactating females. * Patients that are high risk for moderate exercise based on ACSM risk classification. * Patients who exceed minimal physical activity recommendations from the US Surgeon General's Report: Accumulation of 30 minutes or more of moderate physical activity on most days of the week. * Morbidly obese with BMI ≥ 40
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Effects of exercise | Length of study | To assess the effect of an exercise intervention in breast cancer patients with arthralgia secondary to adjuvant treatment with aromatase inhibitors. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Feasibility of Multi-institutional study | Length of the study | To perform a pilot to access the feasibility of a multi-institutional approach |
Countries
United States